F
Foghorn Therapeutics D
D
FHTX
4.90000
USD
0.20
(4.26%)
مغلق
حجم التداول
0
الربح لكل سهم
-1
العائد الربحي
-
P/E
-4
حجم السوق
273,132,728
الأخبار المقالات
العنوان: Foghorn Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.